Despite safety concerns about how the treatment will affect the liver, a panel of medical experts, on Tuesday, voted 10-1 vote for Swiss manufacturer, Roche Holding AG's rheumatoid arthritis drug, Actemra.
In an 11 member panel, 10 members voted in favor of recommending approval, while one voted against the idea.
Though it is not mandatory for the U.S. Food and Drug Administration, who sponsored the panel, to follow its recommendations, but it invariably does so. FDA’s final decision on whether to approve the drug or not is expected by September 18.
Effective in treating rheumatoid arthritis, or RA, in adults - a progressive joint damaging disease that can lead to disability – Actemra blocks interleukin-6 (IL-6), an immune-system protein the spurs inflammation. A highly painful condition, in severe cases the disorder can destruct other organs including the lungs and skin.
Conversely, other widely used drugs block a protein called tumor necrosis factor (TNF).
Though the drug’s ability to relieve symptoms outweighed the potential risks, members on panel urged regular monitoring of patients' liver function and cholesterol levels, as laboratory tests of the drug showed elevated liver enzymes and increased LDL or "bad" cholesterol in some patients.
"The safety concerns are real, and I think there is going to have to be monitoring," said panel member Dr. David Felson, clinical epidemiology chief at Boston University School of Medicine.
New Delhi, November 4 -- The relentless rampage of the current H1N1 monster shows no sign of abating with two more succumbing to the lethal virus Tuesday, taking the total number of fatalities in the nation to 477.
We seeks happiness even as it continues to elude many of us. However, the fact is that if we focus our attention on other things and not strive for happiness itself, we will experience this emotion more often.
You have just met your Mr. Right and with all your womanly intuition you feel that he is the one you have been waiting for. You are excited, can`t stop smiling and your cheeks turn red the moment he enters.
Disclaimer: The views and ideas expressed by medical experts on themedguru.com are their own, and not that of the website or its management. TheMedGuru advises users to check with their certified experts for their healthcare needs.
The comments and views posted by readers are their own and not that of the website or its management. Please see our 'Terms of Service' for details.
Post new comment